Calcium D-Glucarate vs TUDCA (Tauroursodeoxycholic Acid)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Calcium D-GlucarateTUDCA (Tauroursodeoxycholic Acid)
CategorySupplementsSupplements
Standard Dose500-1500mg daily250-500mg daily
TimingWith meals, split 2-3x/day for sustained beta-glucuronidase inhibition.With meals for liver support. Some protocols recommend before meals to prime bile flow.
Cycle Durationongoing or cycle with DIM protocolCycle 4-8 weeks for liver support; ongoing at low dose for chronic liver conditions under supervision
Evidence Levelmoderate_humanModerate-Strong

Mechanism

Calcium D-glucarate is the calcium salt of D-glucaric acid, which is metabolized to D-glucaro-1,4-lactone (the active metabolite). This lactone inhibits beta-glucuronidase, the bacterial enzyme in the gut that deconjugates (cleaves) glucuronide conjugates from Phase II detoxification. By inhibiting beta-glucuronidase, calcium D-glucarate prevents the reabsorption (enterohepatic recirculation) of estrogen, environmental toxins, and carcinogens that were already conjugated for excretion. This effectively enhances the elimination of glucuronidated compounds, including estrogen metabolites, bilirubin, and xenobiotics.

Standard Dosing

500-1500mg daily

Timing

With meals, split 2-3x/day for sustained beta-glucuronidase inhibition.

Cycle Duration

ongoing or cycle with DIM protocol

Side Effects

  • GI discomfort
  • Loose stools
  • Generally very well tolerated

Contraindications

  • Pregnancy/lactation (estrogen clearance effects)
  • Concurrent medications with narrow therapeutic index that undergo glucuronidation

Best Stacking Partners

DIMSulforaphaneNACProbiotics (to modulate gut beta-glucuronidase-producing bacteria)

Mechanism

TUDCA is a water-soluble bile acid conjugate (taurine + ursodeoxycholic acid) with potent hepatoprotective and cytoprotective properties. It inhibits the mitochondrial pathway of apoptosis by preventing BAX translocation to mitochondria and cytochrome c release. TUDCA reduces endoplasmic reticulum (ER) stress by acting as a chemical chaperone, assisting protein folding and reducing the unfolded protein response (UPR). It protects hepatocytes by stabilizing cell membranes, displacing toxic hydrophobic bile acids (chenodeoxycholic, lithocholic) from biliary epithelium, and promoting choleresis (bile flow). Additionally, it has neuroprotective effects via reduction of ER stress in neurons and modulation of the TGR5 bile acid receptor.

Standard Dosing

250-500mg daily

Timing

With meals for liver support. Some protocols recommend before meals to prime bile flow.

Cycle Duration

Cycle 4-8 weeks for liver support; ongoing at low dose for chronic liver conditions under supervision

Side Effects

  • Diarrhea (dose-dependent)
  • GI discomfort
  • Flatulence
  • Rare: calcification of gallstones

Contraindications

  • Complete biliary obstruction (cannot reach bile ducts if obstruction is complete)
  • Calcified gallstones (UDCA/TUDCA dissolve cholesterol stones, not calcified)
  • Acute cholangitis
  • Complete biliary obstruction
  • Gallstones (may mobilize stones)

Best Stacking Partners

Milk Thistle (Silymarin)NACAlpha Lipoic AcidArtichoke Extract

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →